Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2009 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
Gan-Shmuel Foods, Ltd.
Information provided by:
Hillel Yaffe Medical Center Identifier:
First received: September 29, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
It has been shown in laboratory studies that pomegranate juice contains anti-viral action against influenza. The researchers wish to investigate the effect of pomegranate juice on patients suffering from influenza A (seasonal or swine flu).

Condition Intervention
Influenza A
Swine Flu
Dietary Supplement: Pomegranate juice
Dietary Supplement: Placebo drink

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator)
Primary Purpose: Treatment
Official Title: The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients - A Prospective Randomized Trial

Resource links provided by NLM:

Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Early relief of influenza symptoms [ Time Frame: Within one week ]

Estimated Enrollment: 200
Study Start Date: October 2009
Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Pomegranate juice Dietary Supplement: Pomegranate juice
Twice daily ingestion of pomegranate juice over 4-5 days
Placebo Comparator: Placebo drink Dietary Supplement: Placebo drink
Twice daily ingestion of placebo drink over 4-5 days


Ages Eligible for Study:   12 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Individuals confirmed and suffering from Influenza A

Exclusion Criteria:

  • Individuals suffering from influenza included in the high risk group
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00987012

Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Contact: Gershon Keren, MD    972-4-6304218   
Contact: Izhak Braverman, MD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
Gan-Shmuel Foods, Ltd.
  More Information

Responsible Party: Dr. Gershon Keren, Hillel Yaffe Medical Center Identifier: NCT00987012     History of Changes
Other Study ID Numbers: 0044-09-HYMC
Study First Received: September 29, 2009
Last Updated: September 29, 2009

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases processed this record on May 25, 2017